Business Description
Unity Biotechnology Inc
NAICS : 325411
SIC : 2833
ISIN : US91381U2006
Description
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.46 | |||||
9-Day RSI | 39.23 | |||||
14-Day RSI | 39.55 | |||||
3-1 Month Momentum % | -32.47 | |||||
6-1 Month Momentum % | -92.77 | |||||
12-1 Month Momentum % | -95.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-Revenue | 211.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:UNBX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Unity Biotechnology Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.62 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.5 | ||
| 3-Year Sortino Ratio | -0.76 | ||
| Volatility % | 170.66 | ||
| 14-Day RSI | 39.55 | ||
| 14-Day ATR ($) | 0.008933 | ||
| 20-Day SMA ($) | 0.058598 | ||
| 12-1 Month Momentum % | -95.2 | ||
| 52-Week Range ($) | 0.0487 - 3.1 | ||
| Shares Outstanding (Mil) | 17.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Unity Biotechnology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Unity Biotechnology Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2026-08-14 | In 41 days | ||
| First quarter earnings results for 2026 | 2026-04-22 16:30 | 0.06 (+0.00%) | ||
| Annual report for 2025 | 2026-03-06 | 0.06 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-06 | 0.06 (+0.00%) | ||
| General meeting for 2025 | 2026-02-10 | 0.06 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2026-02-10 | 0.06 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-04 | 0.06 (+0.00%) | ||
| General meeting for 2025 | 2025-10-17 | 0.06 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-10-15 | 0.06 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-10-08 | 0.06 (+0.00%) |
Show
Entries
Unity Biotechnology Inc Frequently Asked Questions
What is Unity Biotechnology Inc(UNBX)'s stock price today?
The current price of UNBX is $0.06. The 52 week high of UNBX is $3.10 and 52 week low is $0.05.
When is next earnings date of Unity Biotechnology Inc(UNBX)?
The next earnings date of Unity Biotechnology Inc(UNBX) is 2026-08-14 Est..
Does Unity Biotechnology Inc(UNBX) pay dividends? If so, how much?
Unity Biotechnology Inc(UNBX) does not pay dividend.
Guru Commentaries on OTCPK:UNBX
No articles.
Press Release
Articles on Unity Biotechnology Inc
No articles.